| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8807186 | Annals of Diagnostic Pathology | 2018 | 6 Pages |
Abstract
COX2 expression is a marker of invasion, recurrence and poor survival and may have a role in predicting the cases which will benefit from additional treatment with COX2 inhibitors in urothelial carcinoma.
Keywords
RT-PCRTURBTcox2BCGGAPDHNSAIDmRNAnatural killerFFPEIHCImmunohistochemistryBacillus Calmette GuerinTransurethral resection of bladder tumorTILanalysis of varianceANOVATumor infiltrating lymphocytesmessenger ribonucleic acidUrothelial bladder cancercyclo-oxygenase 2Non-steroidal anti-inflammatory drugformalin fixed paraffin embeddedreal-time polymerase chain reactionglyceraldehyde 3-phosphate dehydrogenase
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Usha Agrawal, Nitu Kumari, Pawan Vasudeva, Nayan K. Mohanty, Sunita Saxena,